LAURUSLABS — Laurus Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Laurus Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	48,135	49,356	60,406	50,408	55,540
Cost of Revenue
Gross Profit	24,584	24,828	28,757	22,036	30,760
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	34,632	37,610	47,469	46,460	49,288
Operating Profit	13,504	11,746	12,936	3,949	6,252
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13,011	10,839	11,089	2,364	4,843
Provision for Income Taxes
Net Income After Taxes	9,838	8,324	7,966	1,682	3,544
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	9,836	8,275	7,901	1,606	3,583
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9,836	8,275	7,901	1,606	3,583
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	18.3	15.4	14.6	3	6.64
Dividends per Share